mHealth to Help Pregnant and Postpartum Women in Recovery for Opioid Use Disorder
NCT ID: NCT06701123
Last Updated: 2024-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
69 participants
INTERVENTIONAL
2023-07-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This novel technology could be an invaluable tool to assist physicians in the treatment of OUD among PPW.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
NCT05942313
Maternal Brain Imaging in Opioid Use Disorder
NCT06008990
Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People
NCT06496230
Neonatal and Maternal Effects of Buprenorphine and Methadone
NCT03024736
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
NCT04049799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Intervention : Control Group Access to uMAT-R but did not engage
No Intervention : Control Group Access to uMAT-R but did not engage
No interventions assigned to this group
Experimental : Experimental Group A- Mobile App with Coaching Feature
Access to a coached program on uMAT-R App
uMAT-R mobile app with coaching component
uMAT-R recovery mobile app with coaching component
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uMAT-R mobile app with coaching component
uMAT-R recovery mobile app with coaching component
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Receiving treatment at CARE
3. Adult (≥18 years of age)
4. U.S. resident
5. Currently on MAT
6. Fluent in English
7. women with opioid use disorder (OUD)
Exclusion Criteria
9. Patients with acute suicidality or psychotic disorders as assessed by CARE providers
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201805132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.